Web1 day ago · Alentis Therapeutics is a clinical-stage biotech developing treatments for organ fibrosis and claudin-1 (CLDN1) positive tumors. The company has announced $105 million in Series C financing. The funding round was led by Jeito Capital, Novo Holdings A/S and RA Capital Management with participation from existing investors including BB Pureos ... WebMar 22, 2024 · Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo ...
Dr. Mari Mitrani - Chief Science Officer and Co-Founder - LinkedIn
WebGalapagos has raised a total of $5.4B in funding over 14 rounds. Their latest funding was raised on Jul 14, 2024 from a Post-IPO Equity round. Galapagos is registered under the ticker VIE:GLPG . Galapagos is funded by 6 investors. Gilead Sciences and University of Antwerp are the most recent investors. Galapagos has invested in Vitalnext on Jul ... WebAug 10, 2024 · FLORA was an exploratory, randomized, double-blind, placebo-controlled trial investigating a once- daily oral dose of GLPG1690. The drug candidate was administered for 12 weeks in 23 IPF patients, 17 of whom received GLPG1690 and 6 placebo. Primary objectives of the trial were to assess safety, tolerability, … bath loofah pads
Galapagos provides further insights into the treatment of
WebJun 10, 2024 · Oxford, UK, 10 th June 2024: e-therapeutics plc (AIM: ETX.L, “e-therapeutics” or “the Company”) today announces that it has entered a collaboration agreement with Galapagos NV (“Galapagos”) to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF) and … WebApr 11, 2024 · Posted by Defense World Staff on Apr 11th, 2024. Galapagos NV ( NASDAQ:GLPG – Get Rating )’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200 ... WebSep 17, 2024 · Galapagos NV discovers, develops, and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through Phase 3 programs in inflammation, fibrosis, and ... telekom fiksna mreza